Factors Associated of Multidrug-Resistance Tuberculosis among Minangkabau Ethnicity in Indonesia
DOI:
https://doi.org/10.3889/oamjms.2022.8980Keywords:
MDR-TB, Risk factors, Minangkabau ethnicity, IndonesiaAbstract
BACKGROUND: Past tuberculosis therapy has been linked to an increased chance of developing multidrug-resistant tuberculosis (MDR-TB). Indonesia is placed 8th among the 27 nations with "high-burden" MDR-TB.
AIM: The purpose of this study was to determine the risk factors associated of multidrug-resistance tuberculosis among minangkabau ethnicity in Indonesia.
METHODS: The authors conducted a case control study. Data were gathered in Dr. M Djamil General Hospital Padang, Lubuk Alung Hospital Pariaman and Primary Health Care in Padang Pariaman District from December 2019-March 2020. In this study, there were 73 cases (MDR-TB) and 219 controls (Tuberculosis) who were matched by age and sex. The sampling technique in this research was convenience sampling. Data were gathered from medical records. Bivariate and multivariate analysis were investigated using chi-square and logistic binary regression test. The data were analyzed using STATA version 14.2.
Results: The risk factors for MDR-TB, cavitary pulmonary had the highest odds ratio (OR = 113.54 [95% CI 15.02-858.54]), followed by TB outside the lung (OR = 38,68 [95% CI 4.89-305.43]), nutritional status (OR = 10.92 [95% CI 5.79-20.56]), alcohol consumption (OR = 6.45 [95% CI 1.57-26.48]), working status (OR = 4.08 [95% CI 2.33-7.17]), level of education (OR = 2.79 [95% CI 1.61-4.85]), history of close contact to patients with MDR-TB and TB (OR = 2.35 [95% CI 1.30-4.22]) and diabetes mellitus (OR = 2.12 [95% CI 1.15-3.91]). Multivariate analysis found that patients with a cavitary pulmonary was significant dominant factors for MDR-TB.
Conclusion: MDR-TB was predicted by previous tuberculosis therapy and cavitary pulmonary disease.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
World Health Organization. World Health Organization Multidrug and Extensively Drug-Resistant TB (M/XDR-TB): 2010 Global Report on Surveillance and Response. Geneva, Switzerland: World Health Organization; 2010. https://doi.org/10.26719/2015.21.6.379 DOI: https://doi.org/10.26719/2015.21.6.379
World Health Organization. World Health Organization Global Tuberculosis Control Report 2009. Global Tuberculosis Control. Geneva: World Health Organization; 2011. https://doi.org/10.2471/blt.06.037820 DOI: https://doi.org/10.2471/BLT.06.037820
Ministry of Health Republic of Indonesia. Indonesia Health Profile 2014. Jakarta: Ministry of Health Republic of Indonesia; 2014. https://doi.org/10.18311/jeoh/2020/26134 DOI: https://doi.org/10.18311/jeoh/2020/26134
Nindrea RD, Sari NP, Harahap WA, Haryono SJ, Kusnanto H, Dwiprahasto I, et al. Survey data of multidrug-resistant tuberculosis, tuberculosis patients characteristics and stress resilience during COVID-19 pandemic in West Sumatera Province, Indonesia. Data Brief. 2020;32:106293. https://doi.org/10.1016/j.dib.2020.106293 PMid:32923551 DOI: https://doi.org/10.1016/j.dib.2020.106293
Suarez-Garcia I, Rodriguez-Blanco A, Vidal-Perez J, Garcia- Viejo M, Jaras-Hernandez M, Lopez O, et al. Risk factors for multidrug-resistant tuberculosis in a tuberculosis unit in Madrid, Spain. Eur J Clin Microbiol Infect Dis. 2009;28(4):325-30. https://doi.org/10.1007/s10096-008-0627-y PMid:18830725 DOI: https://doi.org/10.1007/s10096-008-0627-y
Alene KA, Viney K, McBryde ES, Tsegaye AT, Clements AC. Treatment outcomes in patients with multidrug-resistant tuberculosis in North-West Ethiopia. Trop Med Int Health. 2017;22(3):351-62. https://doi.org/10.1111/tmi.12826 PMid:27978594 DOI: https://doi.org/10.1111/tmi.12826
Aung MM, Naing N, Rusli AM, Jaeb M, Zuki M, Wan-Arfah N, et al. Risk factors associate with recurrence of tuberculosis and multidrug-resistant tuberculosis at the chest clinic, hospital Raja Perempuan Zainab II Kota Bharu Malaysia. Int J Pharm Sci Res. 2015;7(2):77. https://doi.org/10.7324/japs.2016.60214 DOI: https://doi.org/10.7324/JAPS.2016.60214
Rafiza S, Rampal KG, Tahir A. Prevalence and risk factors of tuberculosis infection among health care workers in Malaysia. BMC Infect Dis. 2011;11(1):19. https://doi.org/10.1186/1471-2334-11-19 DOI: https://doi.org/10.1186/1471-2334-11-19
Wang K, Chen S, Wang X, Zhong J, Wang X, Huai P, et al. Factors contributing to the high prevalence of multidrug-resistant tuberculosis among previously treated patients: A case-control study from China. Microb Drug Resist. 2014;20(4):294-300. https://doi.org/10.1089/mdr.2013.0145 PMid:24328894 DOI: https://doi.org/10.1089/mdr.2013.0145
Elmi OS, Hasan H, Abdullah S, Jeab MZ, Nadiah WA, Ba Z, et al. Factors associated with new and previously treated multidrug-resistant tuberculosis in Malaysia: A retrospective record review study. Int Med J. 2014;21(5):1-5. https://doi.org/10.5455/ijmsph.2014.110120141 DOI: https://doi.org/10.5455/ijmsph.2014.110120141
Silva DR, Muñoz-Torrico M, Duarte R, Galvão T, Bonini EH, Arbex FF, et al. Risk factors for tuberculosis: Diabetes, smoking, alcohol use, and the use of other drugs. J Bras Pneumol. 2018;44(2):145-52. https://doi.org/10.1590/s1806-37562017000000443 PMid:29791552 DOI: https://doi.org/10.1590/s1806-37562017000000443
Soeroto AY, Pratiwi C, Santoso P, Lestari BW. Factors affecting outcome of longer regimen multidrug-resistant tuberculosis treatment in West Java Indonesia: A retrospective cohort study. PLoS One. 2021;16(2):e0246284. https://doi.org/10.1371/journal.pone.0246284 DOI: https://doi.org/10.1371/journal.pone.0246284
Lasebikan VO, Ige OM. Alcohol use disorders in multidrug resistant tuberculosis (MDR-TB) patients and their non-tuberculosis family contacts in Nigeria. Pan Afr Med J. 2020;36:321. https://doi.org/10.11604/pamj.2020.36.321.17118 PMid:33193975 DOI: https://doi.org/10.11604/pamj.2020.36.321.17118
Desissa F, Workineh T, Beyene T. Risk factors for the occurrence of multidrug-resistant tuberculosis among patients undergoing multidrug-resistant tuberculosis treatment in East Shoa, Ethiopia. BMC Public Health. 2018;18(1):422. https://doi.org/10.1186/s12889-018-5371-3 PMid:29606112 DOI: https://doi.org/10.1186/s12889-018-5371-3
Seung KJ, Keshavjee S, Rich ML. Multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis. Cold Spring Harb Perspect Med. 2015;5(9):a017863. https://doi.org/10.1101/cshperspect.a017863 PMid:25918181 DOI: https://doi.org/10.1101/cshperspect.a017863
Tegegne BS, Mengesha MM, Teferra AA, Awoke MA, Habtewold TD. Association between diabetes mellitus and multi-drug-resistant tuberculosis: Evidence from a systematic review and meta-analysis. Syst Rev. 2018;7(1):161. https://doi.org/10.1186/s13643-018-0828-0 PMid:30322409 DOI: https://doi.org/10.1186/s13643-018-0828-0
Nyaki FS, Taksdal M, Mbuya AW, Sariko M, Lekule IA, Kisonga RM, et al. Predictors of nutritional status in patients treated for multidrug-resistant tuberculosis at a referral hospital in Tanzania. Oman Med J. 2016;1(2):1-5. https://doi.org/10.4172/2476-213x.1000115 DOI: https://doi.org/10.4172/2476-213X.1000115
Kurniawati F, Sulaiman SA, Gillani W. Study on drug-resistant tuberculosis and prevalence. Study on drug resistant tuberculosis and prevalence on patients with drug resistant tuberculosis in chest clinic outpatient department. Int J Pharm Pharm Sci. 2012;4(2):733-7. https://doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a1826 DOI: https://doi.org/10.1164/ajrccm-conference.2011.183.1_MeetingAbstracts.A1826
Caminero JA. Multidrug-resistant tuberculosis: Epidemiology, risk factors and case finding. J Int Tuberc Lung Dis. 2010;14(4):382-90. PMid:20202293
Mesfin YM, Hailemariam D, Biadgilign S, Kibret KT. Association between HIV/AIDS and multi-drug resistance tuberculosis: A systematic review and meta-analysis. PloS One. 2014;9(1):e82235. https://doi.org/10.1371/journal.pone.0082235 PMid:24416139 DOI: https://doi.org/10.1371/journal.pone.0082235
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2022 Ambun Kadri, Rizanda Machmud, Andani Putra, Ahmad Syafruddin Indrapriyatna (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0
